Différences entre versions de « Insuffisance rénale chronique »
De médecine.top
| Ligne 10 : | Ligne 10 : | ||
The Kidney Disease: Improving Global Outcomes guidelines recommend treatment with a statin in all patients with non-dialysis–dependent chronic kidney disease (CKD) who are over 50 years of age and in adults 18 to 49 years of age with non-dialysis–dependent CKD and any one of the following: coronary disease, diabetes mellitus, prior ischemic stroke, or a >10% estimated risk of coronary death or nonfatal myocardial infarction. | The Kidney Disease: Improving Global Outcomes guidelines recommend treatment with a statin in all patients with non-dialysis–dependent chronic kidney disease (CKD) who are over 50 years of age and in adults 18 to 49 years of age with non-dialysis–dependent CKD and any one of the following: coronary disease, diabetes mellitus, prior ischemic stroke, or a >10% estimated risk of coronary death or nonfatal myocardial infarction. | ||
| − | == Calcium == | + | == Calcium et vitamine D == |
| − | + | KDIGO guidelines recommend that patients with an eGFR <60 mL/min/1.73 m2 (stage G3-G5) be evaluated for 25-hydroxyvitamin D deficiency and supplemented as per guidelines for the general population. | |
[[Category:Néphrologie]] | [[Category:Néphrologie]] | ||
Version du 16 juin 2020 à 15:05
- Facteurs prédictifs de progression vers l'insuffisance rénale terminale:
- Niveau basal de l'eGFR
- Degré de protéinurie/albuminurie
Tension artérielle
- IEC/ARB si stade KDIGO G3a ou au-delà ou si stade G1/G2 avec albuminurie, diurétiques de l'anse
- Cible: <130/80 mmHg
Lipides
The Kidney Disease: Improving Global Outcomes guidelines recommend treatment with a statin in all patients with non-dialysis–dependent chronic kidney disease (CKD) who are over 50 years of age and in adults 18 to 49 years of age with non-dialysis–dependent CKD and any one of the following: coronary disease, diabetes mellitus, prior ischemic stroke, or a >10% estimated risk of coronary death or nonfatal myocardial infarction.
Calcium et vitamine D
KDIGO guidelines recommend that patients with an eGFR <60 mL/min/1.73 m2 (stage G3-G5) be evaluated for 25-hydroxyvitamin D deficiency and supplemented as per guidelines for the general population.
